Whole-leaf aloe vera extract is classified by the International Agency for Research on Cancer (IARC) as a “possible human carcinogen” (Group 2B), based primarily on a landmark U.S. government study that found it caused intestinal tumors in rats. That sounds alarming for a plant sitting on millions of kitchen windowsills, but the classification comes with critical context that most headlines skip. The cancer risk is tied to specific compounds concentrated in the plant’s outer leaf, not the clear inner gel that most people encounter in commercial products. The gap between a rat drinking nondecolorized whole-leaf extract for two years and a person applying aloe gel to a sunburn is enormous, and worth understanding in detail.
The Rat Study That Started the Alarm
The evidence behind the IARC classification rests heavily on a two-year study conducted by the U.S. National Toxicology Program (NTP). Researchers gave rats and mice drinking water containing nondecolorized whole-leaf aloe vera extract at several doses. The results in rats were striking: the extract caused cancers of the large intestine in both males and females, along with widespread hyperplasia (abnormal cell growth) in the large intestine, small intestine, stomach, and lymph nodes.1National Toxicology Program technical report series. Toxicology and carcinogenesis studies of a nondecolorized whole leaf extract of Aloe barbadensis Miller (Aloe vera) in F344/N rats and B6C3F1 mice (drinking water study) Based on this, a comprehensive toxicity review noted that aloe vera whole leaf extract was subsequently classified by the IARC as a Group 2B possible human carcinogen.2PubMed Central. Aloe vera: A review of toxicity and adverse clinical effects
Two things are worth noting. First, the extract was “nondecolorized,” meaning it had not been filtered to remove the pigmented, anthraquinone-rich compounds found in the plant’s latex layer. Most commercial aloe products go through a decolorization process specifically to strip those compounds out. Second, the animals consumed the extract continuously in their drinking water for their entire lives. That is a standard approach in toxicology testing, designed to reveal hazards at high cumulative exposure, but it does not map neatly onto how most people actually use aloe.
What Part of the Plant Is the Problem
An aloe vera leaf is not one uniform substance. The clear inner gel, which makes up the bulk of the leaf, is mostly water with a small fraction of polysaccharides and other solids.3Advanced Journal of Science, Technology and Engineering. Extraction, Stabilization and GC-MS Characterization of Ethanolic Leaf Extracts of Aloe Vera Gel and Rind Sandwiched between the gel and the tough outer rind is a thin layer of yellow latex. This latex is where the plant concentrates its anthraquinone compounds, particularly aloin A and aloin B. These are the molecules that give aloe its well-known laxative kick, and they are also the ones that concern toxicologists.
When researchers and regulators talk about aloe vera’s cancer risk, they are talking about these anthraquinone-containing fractions. The inner gel, on its own, contains very little of them. The whole-leaf extract used in the NTP study, by contrast, included everything: gel, latex, and rind. Chemical analysis of aloe confirms that the plant contains various polysaccharides alongside these phenolic chemicals, with anthraquinones being the most notable concern.2PubMed Central. Aloe vera: A review of toxicity and adverse clinical effects The distinction between “aloe vera” the whole leaf and “aloe vera gel” the processed product matters enormously.
How Gut Bacteria Turn Aloin Into Something Worse
Aloin itself is not the end of the story. When you swallow it, bacteria in your large intestine break it down. The conversion pathway goes from aloin to an intermediate called aloe-emodin-9-anthrone, and then through oxidation to aloe-emodin, a free anthraquinone.4Toxicological Sciences. From the Cover: Aloin, a Component of the Aloe Vera Plant Leaf, Induces Pathological Changes and Modulates the Composition of Microbiota in the Large Intestines of F344/N Male Rats Multiple bacterial species can perform this conversion, including common gut residents.5PubMed Central. Dose-Dependent Effects of Aloin on the Intestinal Bacterial Community Structure, Short Chain Fatty Acids Metabolism and Intestinal Epithelial Cell Permeability
Aloe-emodin is where the trouble concentrates. In lab studies on human lung cancer cells, aloe-emodin at moderate concentrations caused DNA single-strand breaks and suppressed the activity of DNA repair enzymes, with the damage driven by the generation of reactive oxygen species.6PubMed. Aloe-emodin induced DNA damage through generation of reactive oxygen species in human lung carcinoma cells Separately, when human skin cells were treated with aloe-emodin and then exposed to UV or visible light, researchers observed significant cell death accompanied by oxidative damage to both DNA and RNA. Interestingly, aloin A at concentrations 25 times higher did not produce the same photocytotoxicity, suggesting the parent compound is far less dangerous than what gut bacteria turn it into.7Free Radical Biology and Medicine. In vitro studies on the photobiological properties of aloe emodin and aloin A
This matters because the conversion happens specifically in the large intestine, exactly where the NTP study found tumors. Aloin administration in rats produced dose-dependent hyperplasia stretching from the cecum to the rectum, along with significant shifts in the composition of the gut microbiome.8PubMed Central. From the Cover: Aloin, a Component of the Aloe Vera Plant Leaf, Induces Pathological Changes and Modulates the Composition of Microbiota in the Large Intestines of F344/N Male Rats So the picture is reasonably coherent: aloin arrives in the colon, gut bacteria convert it to aloe-emodin, and aloe-emodin generates oxidative stress that damages cells locally. Over long periods, that chronic irritation and DNA damage could promote tumor formation.
What About People, Not Rats
The obvious question is whether any of this translates to humans. Here the evidence gets much thinner. There are no published human clinical trials or epidemiological studies that directly link aloe vera consumption to cancer in people. What researchers have looked at instead is whether chronic use of anthraquinone-containing laxatives (a broader category that includes aloe-derived products alongside senna and cascara) is associated with colorectal cancer.
A Japanese cohort study following over 41,000 people for seven years found that frequent laxative users, meaning those using laxatives at least twice a week, had roughly 2.75 times the risk of colon cancer compared to non-users. The association held for colon cancer specifically but not rectal cancer.9PubMed. Constipation, laxative use and risk of colorectal cancer: The Miyagi Cohort Study That number sounds concerning, but it comes with a classic chicken-and-egg problem: people who use laxatives frequently tend to be chronically constipated, and constipation itself may independently raise colon cancer risk through prolonged contact between stool and the intestinal lining.
A larger meta-analysis pooling 12 studies and over 415,000 patients reached a different conclusion, finding that laxative use overall was not significantly associated with colorectal cancer risk. Subgroup analyses breaking the data down by laxative type also showed no significant influence for most laxative types, with the exception of fiber laxatives, which are chemically unrelated to anthraquinones.10PubMed Central. Effect of laxative use and laxative type on colorectal cancer risk: A pooling up analysis and evidence synthesis That is a fairly substantial contradiction. The most likely explanation is that confounding factors like chronic constipation, diet, and underlying bowel disease muddy the signal in observational studies. It is genuinely unclear, based on the human data available, whether the anthraquinones in aloe-type laxatives raise cancer risk in people who use them at typical doses.
What “Group 2B” Actually Means
When the IARC puts something in Group 2B, it means there is limited evidence of carcinogenicity in humans and less than sufficient evidence overall, but enough concern that the possibility cannot be dismissed. This is a hazard classification, not a risk assessment. It identifies whether something can potentially cause cancer under some conditions, not whether it will cause cancer at the doses you encounter in daily life. Group 2B is a crowded category. It includes things like pickled vegetables, aloe vera whole leaf extract, and radiofrequency electromagnetic fields from cell phones. The presence of a substance in Group 2B tells you that the evidence is suggestive but incomplete, not that using the substance will give you cancer.
For aloe vera specifically, the Group 2B classification applies to “aloe vera whole leaf extract,” not to the inner gel. The IARC made this distinction deliberately. The evidence of carcinogenicity came from the NTP study using nondecolorized whole-leaf extract. The gel fraction was not implicated in the same way.
Decolorization and Commercial Products
Most aloe vera products sold for consumption, including juices, supplements, and food-grade gels, go through a process called decolorization. This typically involves filtering the raw extract through activated charcoal, which strips out the pigmented anthraquinone compounds. The result is a product with only trace residual amounts of aloin and aloe-emodin, classified as unavoidable impurities rather than active constituents.11Toxicology Reports. Absence of genotoxicity of purified Aloe vera whole leaf dry juice as assessed by an in vitro mouse lymphoma tk assay and an in vivo comet assay in male F344 rats
This is a meaningful safety step. The NTP study used a nondecolorized extract precisely because the goal was to test the whole plant’s toxicity, not the processed commercial product. When you buy aloe vera juice at a grocery store, the anthraquinone content should be drastically lower than what the rats consumed. That said, “should be” is doing some work in that sentence. Not all aloe products are created equal. Some herbal supplements and whole-leaf preparations may not undergo thorough decolorization. Analytical methods now exist to measure aloin and aloe-emodin levels in consumer products, and testing has shown that concentrations vary across brands and product types.12Analytical Methods. Simultaneous determination of aloin A and aloe emodin in products containing Aloe vera by ultra-performance liquid chromatography with tandem mass spectrometry If you are consuming aloe vera internally on a regular basis, choosing products that are labeled as decolorized or purified is a reasonable precaution.
Topical Use Is a Different Story
Most people encounter aloe vera not as a drink but as something they smear on a sunburn or mix into a skin-care product. The cancer question is almost entirely about oral consumption, because the relevant mechanism depends on gut bacteria converting aloin into aloe-emodin inside the colon. When you apply aloe gel to your skin, that intestinal conversion pathway does not come into play.
In fact, the evidence on topical aloe vera points in the opposite direction. Lab studies have shown that aloe vera extract protects cells against UV-induced photodamage by helping maintain the integrity of cellular membranes, particularly lysosomes. This protection was observed even though the aloe extract itself did not act as a free radical scavenger in the traditional sense, suggesting it works by a different mechanism than conventional antioxidants.13PubMed. Mechanism of Aloe Vera extract protection against UVA: shelter of lysosomal membrane avoids photodamage More recent research using nanoparticles derived from aloe vera gel and rind found that they reduced oxidative stress and DNA damage from UV exposure and delayed markers of skin photoaging in mice, with good safety profiles.14PubMed Central. Aloe Vera Gel and Rind-Derived Nanoparticles Mitigate Skin Photoaging via Activation of Nrf2/ARE Pathway
So the situation is somewhat counterintuitive: the same plant whose internal compounds raise cancer concerns when swallowed may help protect skin cells from UV damage when applied externally. This is not as contradictory as it sounds. The harmful effects depend on a specific chain of events: oral ingestion, bacterial metabolism in the colon, local generation of aloe-emodin, and chronic oxidative stress to the intestinal lining. Topical application skips every step of that chain.
The Aloe-Emodin Paradox
Something genuinely strange about aloe-emodin is that the same compound flagged for promoting DNA damage in the colon has also been studied extensively as a potential anti-cancer agent. A systematic review of the literature found that aloe-emodin exhibits an array of anti-tumor effects across various cancer cell lines, including triggering cell death through both internal and external pathways, arresting the cell cycle, modulating immune signaling, and altering cell mobility.15PubMed Central. Anti-cancer effects of aloe-emodin: a systematic review
This is less paradoxical than it first appears. Many substances that damage DNA can both promote cancer (by causing mutations in healthy cells) and kill cancer cells (by overwhelming already-damaged cells with additional stress). Chemotherapy drugs work on a similar principle. The difference is context: a low, chronic dose of DNA-damaging compounds hitting healthy colon tissue over years could promote tumors, while a high, acute dose directed at cancer cells in a petri dish could trigger those cells to self-destruct. These are not competing findings so much as two faces of the same property. No one is seriously proposing that you drink aloe latex to treat cancer, and the anti-tumor research is almost entirely confined to cell culture and animal studies.
Practical Takeaways for Common Uses
If you use aloe vera gel on your skin for burns, moisturizing, or minor wound care, the carcinogenicity question is essentially irrelevant to you. The concern applies to oral consumption of anthraquinone-containing aloe products, and even there the risk depends heavily on what exactly you are consuming and how often.
For people who drink aloe vera juice occasionally, the practical risk from a decolorized, commercially filtered product appears very low. The anthraquinones that drove the NTP findings should be largely absent after proper processing. Where caution makes more sense is with whole-leaf aloe supplements, homemade aloe preparations that include the latex, or any product marketed as “whole leaf” or “unfiltered” that has not gone through decolorization. If you are using aloe-containing laxatives regularly, the laxative question applies whether the product is aloe-based or uses a different anthraquinone source like senna. Chronic, frequent use of stimulant laxatives is worth discussing with a doctor regardless of the specific cancer question, because the broader health effects of ongoing laxative dependence are well documented.
The bottom line that the science supports is narrow and specific: nondecolorized whole-leaf aloe vera extract causes intestinal tumors in rats, the mechanism involves bacterial conversion of aloin to aloe-emodin in the colon, and there is no convincing evidence yet that this translates to cancer in humans at typical exposure levels. IARC’s Group 2B classification is appropriately cautious for a substance where animal evidence is clear but human evidence is absent.
Why Regulation Lags Behind the Research
One frustration for consumers is that aloe vera occupies a regulatory gray zone. In many countries, aloe-containing products can be sold as dietary supplements, cosmetics, or food ingredients under very different rules depending on how they are labeled. A topical gel, an ingestible juice, and a laxative capsule may all contain aloe vera but face completely different oversight. The decolorization step that removes the most concerning compounds is an industry practice, not a universally mandated safety standard. Some manufacturers follow it rigorously and test their finished products for residual anthraquinone levels. Others may not.
The development of sensitive analytical techniques capable of detecting aloin and aloe-emodin at very low concentrations in finished products is a relatively recent advance.12Analytical Methods. Simultaneous determination of aloin A and aloe emodin in products containing Aloe vera by ultra-performance liquid chromatography with tandem mass spectrometry These methods make it possible, in principle, to verify that a product has been properly decolorized. But routine testing is not required in most markets, and consumers have no easy way to confirm anthraquinone levels from a product label. For anyone who consumes aloe products internally on a regular basis, buying from manufacturers who specifically document their decolorization process and test for residual anthraquinones is the most actionable step the current science supports.